Lunit Wins Six-Hospital Public Medical AI Project in Korea

A Public Medical AI Rollout Outside Seoul

Lunit has been selected to supply AI image-analysis systems for a Korean government project aimed at regional responsible medical institutions.

The Ministry of Health and Welfare programme is designed to bring commercial AI care systems into hospitals that provide severe and high-difficulty essential medical services outside the Seoul metropolitan area.

The deployment spans named regional providers rather than a single flagship site.

Chungnam National University Sejong Hospital is included, along with Dankook University Hospital and Ulsan University Hospital.

Jeju National University Hospital is also part of the group, as are Jeonbuk National University Hospital and Chonnam National University Hwasun Hospital.

This is not a consumer health app or a general AI announcement.

It is a public-sector medical imaging rollout across regional providers that will need to work within ordinary hospital routines.

The policy goal is to strengthen regional capacity.

Hospitals outside the Seoul metropolitan area often face staffing and access challenges that differ from those at large institutions in the capital area.

The project does not claim that AI replaces physicians.

It places image-analysis software in hospitals that already carry responsibility for essential services in their regions.

Lunit will provide Lunit INSIGHT CXR for chest X-ray image analysis and Lunit INSIGHT MMG for mammography analysis.

Chungnam National University Sejong Hospital will also receive Lunit INSIGHT DBT for three-dimensional digital breast tomosynthesis.

The product mix covers two common screening routes and one more specialised breast-imaging workflow.

It should also make the hospital implementation easier to assess later.

Editors can track whether the tools are used in chest X-ray reading, mammography reading and DBT analysis rather than treating the rollout as a vague medical AI pilot.

The Government Budget Sets The Scale

The ministry project covers 17 regional responsible medical institutions nationwide and carries a 14.2 billion won budget.

The government will support usage fees so hospitals can introduce commercial AI care systems for direct use in clinical settings.

This funding structure addresses a common barrier to hospital AI adoption, which often falters on procurement and workflow rather than model performance alone.

By supporting usage fees, the ministry is trying to move the systems from vendor demonstrations into daily care environments where radiology teams and hospital operators have to use them.

The clinical target is specific.

Chest X-rays and mammography are routine imaging exams.

They often sit near the start of detection pathways for diseases such as lung cancer and breast cancer.

Lunit's products therefore sit in high-volume diagnostic workflows rather than a narrow experimental specialty.

Lunit Gets Public-Sector Validation, But Hospitals Still Have To Operate It

For Lunit, the selection turns prior deployment experience into a domestic public medical reference.

The company said experience built in medical institutions in Korea and overseas is being recognized through a state-led project in the public medical sector.

Chief executive Seo Beom-seok said the selection recognizes the AI capability of Lunit INSIGHT in public medical care.

He linked the rollout to essential-care capacity and to tools that help medical staff read images with greater speed and accuracy.

The harder work begins inside the hospitals.

AI image analysis has to fit existing radiology workflows, local staffing patterns, reporting processes and clinical responsibility.

The available facts identify the products, the hospitals and the budget; they do not disclose performance benchmarks, go-live dates for each hospital or expected reading-volume targets.

What Matters Now Is Stable Use In Regional Care

The stated policy goal is to reduce regional medical gaps by helping hospitals outside the Seoul metropolitan area adopt AI-based care environments.

If the six deployments settle into routine use, Lunit gains a stronger public-health reference and the ministry gets evidence on whether commercial imaging AI can support regional essential-care capacity.

What matters now is operational, not promotional: whether the six hospitals can use Lunit INSIGHT CXR, Lunit INSIGHT MMG and Lunit INSIGHT DBT in ordinary clinical workflows after the ministry-backed introduction.

The named institutions, the 17-hospital national project frame and the 14.2 billion won budget give editors concrete markers to follow.